health ๐ Cipla Pune unit license cancelled by FDA
The Maharashtra FDA cancelled the drug sale license of Cipla's C&F facility in Wadki, Pune, following irregularities with Reactin Plus Tablets. This action was taken because of unauthorized advertising on the packaging and deficiencies in drug storage and records. The FDA seized drug stock worth โน11.19 lakh after finding these violations during a June inspection. These issues include discrepancies in stock records and medicines stored directly on the floor. Cipla has stated that the matter is sub judice and has contested the FDA's order. ๐